Please login to your online account to display your discounted pricing

anti-HOXA9, Polyclonal, Novus Biologicals™


Manufacturer: novus biologicals canada  NBP224663SS

 View more versions of this product

 Disclaimers

For Research Use Only

Catalog No. NBP224663SS

  • / Each
 

Description & Specifications

Specifications

Conjugate Unlabeled
Immunogen A portion of amino acids 180-230 of human HOXA9 was used as the immunogen for this antibody.
Cross Reactivity Canine
Cross Reactivity Chicken
Cross Reactivity Human
Cross Reactivity Mouse
Cross Reactivity Primate
Cross Reactivity Rat
Test Specificity The amino acid sequence used as immunogen for this antibody is 100% homologous in variola virus, 93% homologus incowpox, camelpox and taderapox virus,86% homologus invaccinia virus and 80% homologus in ectromelia, rabbitpox and monkeypox virus.
Gene Accession No. P31269
Primary or Secondary Primary
Concentration 0.5mg/mL
Gene ID (Entrez) 3205
Formulation 100μg antibody in 200μL PBS containing 0.05% BSA
Applications Immunohistochemistry (Paraffin)
Host Species Rabbit
Format Purified
Monoclonal or Polyclonal Polyclonal
Quantity 0.025mg
Antigen HOXA9
Regulatory Status RUO